Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- DVLT +9% (guidance)
Other news:
- AMD +23.7% (Co and OpenAI announce a 6-gigawatt agreement to power OpenAI's next-gen AI infrastructure across multiple generations of AMD Instinct GPUs)
- IVVD +14.7% (FDA has cleared the company's Investigational New Drug application and provided feedback to advance the company's REVOLUTION clinical program)
- ABVX +12.8% (announces late-breaking presentation of 8-Week ABTECT induction trial results in participants with and without prior inadequate response to advanced therapies)
- CMA +12.6% (Comerica to be acquired by Fifth Third Bancorp (FITB) in all-stock transaction)
- DGNX +9.9% (completes acquisition of Matter DK ApS, strengthening Diginex's AI-driven ESG data and analytics leadership)
- FLY +9.8% (acquires SciTec to advance national security capabilities)
- GLXY +8.8% (announces launch of GalaxyOne)
- ARVN +5.1% (presents late breaking, Phase 1 Clinical Data for ARV-102)
- NIU +4.6% (reports Q3 sales volumes of 465,873 units)
- IMDX +4.2% (reports kidney transplant patient achieved ‘immune reset' with novel therapy and graftassure monitoring)
- KLTR +3.3% (CFO to step down; reaffirms guidance)
- LPA +3.2% (files for 5,041,598 ordinary share offering by selling shareholders)
- SKYT +3.1% (files for $350 mln mixed securities shelf offering)
- NAMM +3.1% (files for 1,750,000 ordinary share offering by selling shareholders)
- BETR +3% (CFO Keven Ryan to retire)
- UUUU +3% (closes upsized offering of 0.75% Convertible Senior Notes due 2031)
- CRTO +2.8% (Criteo & DoorDash (DASH) sign multi-year partnership to expand retail media access)
- SKE +2.6% (files prospectus supplement and entered into offering of 5.21 mln common shares at C$24.00 per common share)
- PLTR +2.4% (OneMedNet selects Palantir to advance healthcare AI and data analytics)
- TSLA +2.1% (teases event tomorrow in video on social media)
- SATS +2% (DISH Research confirms addressable TV unlocks growth in a fragmented market)
- CDNA +2% (announces new IVD products and IVDR certification for AlloSeq Tx and QTYPE at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting)
- ACDC +1.9% (files for 3,171,970 share common stock offering by selling shareholders, relates to convertible preferred stock)
- FFAI +1.9% (Founder and Co-CEO YT Jia shares weekly investor update: FX Finalizes U.S. production assembly plan)
- FCX +1.3% (issues update on PT Freeport Indonesia operations)